- Home
- MOBX vs PDSB Comparison
MOBX vs PDSB Comparison
Compare MOBX & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOBX
- PDSB
- Stock Information
- Founded
- MOBX 2020
- PDSB 2005
- Country
- MOBX United States
- PDSB United States
- Employees
- MOBX N/A
- PDSB N/A
- Industry
- MOBX
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- MOBX
- PDSB Health Care
- Exchange
- MOBX Nasdaq
- PDSB Nasdaq
- Market Cap
- MOBX 57.1M
- PDSB 48.0M
- IPO Year
- MOBX N/A
- PDSB N/A
- Fundamental
- Price
- MOBX $0.94
- PDSB $1.02
- Analyst Decision
- MOBX
- PDSB Strong Buy
- Analyst Count
- MOBX 0
- PDSB 2
- Target Price
- MOBX N/A
- PDSB $10.00
- AVG Volume (30 Days)
- MOBX 1.4M
- PDSB 462.0K
- Earning Date
- MOBX 08-13-2025
- PDSB 11-13-2025
- Dividend Yield
- MOBX N/A
- PDSB N/A
- EPS Growth
- MOBX N/A
- PDSB N/A
- EPS
- MOBX N/A
- PDSB N/A
- Revenue
- MOBX $10,984,000.00
- PDSB N/A
- Revenue This Year
- MOBX N/A
- PDSB N/A
- Revenue Next Year
- MOBX N/A
- PDSB N/A
- P/E Ratio
- MOBX N/A
- PDSB N/A
- Revenue Growth
- MOBX 180.13
- PDSB N/A
- 52 Week Low
- MOBX $0.55
- PDSB $0.85
- 52 Week High
- MOBX $2.47
- PDSB $4.29
- Technical
- Relative Strength Index (RSI)
- MOBX 52.40
- PDSB 36.25
- Support Level
- MOBX $0.79
- PDSB $1.00
- Resistance Level
- MOBX $0.88
- PDSB $1.22
- Average True Range (ATR)
- MOBX 0.09
- PDSB 0.05
- MACD
- MOBX -0.00
- PDSB -0.01
- Stochastic Oscillator
- MOBX 48.61
- PDSB 9.09
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.